A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis.
Charles M BurnsKyle EndresCaroline DerrickAlexandra CooperPatricia FabelNwora Lance OkekeDivya AhujaAmy CorneliMehri S McKellarPublished in: Journal of the American College of Clinical Pharmacy : JACCP (2023)
Most SC pharmacists surveyed considered PrEP to be effective and beneficial for individuals who frequent their pharmacy and are willing to prescribe this therapy if statewide statutes allow. Many felt that pharmacies are an appropriate location to prescribe PrEP but lack a complete understanding of required protocols to manage these patients. Further investigation into facilitators and barriers of pharmacy-driven PrEP are needed to enhance utilization within communities.
Keyphrases
- human immunodeficiency virus
- men who have sex with men
- end stage renal disease
- hepatitis c virus
- ejection fraction
- antiretroviral therapy
- newly diagnosed
- chronic kidney disease
- hiv infected
- peritoneal dialysis
- hiv aids
- primary care
- patient reported outcomes
- bone marrow
- stem cells
- mesenchymal stem cells
- chemotherapy induced